DiabetOmics, Inc. is a global medical diagnostics company pioneering innovative biochemical markers for the detection and monitoring of diabetes and complications related to diabetes. DiabetOmics also offers testing for the detection and monitoring of women with gestational diabetes and preeclampsia using a panel of markers that incorporates our unique patented biomarker glycosylated fibronectin.
CLIA, CAP, ISO13485
Testing of clinical samples performed using Olympus and Siemens clinical diagnostic instrumentation. Autoantibody testing performed using ELISA techniques. Hemoglobin A1c and hemoglobin variants assayed using HPLC.